The Effect of Altitude on Dosing and Response to Erythropoietin in ESRD

For poorly understood reasons, patients with end-stage renal disease (ESRD) differ substantially in their response to treatment with recombinant erythropoietin (EPO). Because hypoxia influences many of the biologic pathways involved in erythropoiesis, the altitude at which a patient lives may affect...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Brookhart, M. Alan, Schneeweiss, Sebastian, Avorn, Jerry, Bradbury, Brian D., Rothman, Kenneth J., Fischer, Michael, Mehta, Jyotsna, Winkelmayer, Wolfgang C.
Format: Artigo
Langue:Inglês
Publié: American Society of Nephrology 2008
Sujets:
Clinical Epidemiology
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC2440305/
https://ncbi.nlm.nih.gov/pubmed/18385423
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1681/ASN.2007111181
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires